HIV Articles
Back
	Diabetes/Weight Gain; NASH, Ethnicity in HIV+ at IDWeek 2019 Oct 2-6 Wash DC       IDWeek: BMI and ASCVD Risk Score Changes in Virologically Suppressed Patients with HIV Infection Switching from TDF to TAF Containing ART - (10/11/19)   IDWeek 2019: The Effect of Initiating INSTI-based vs. NNRTI-based Antiretroviral Therapy on Progression to Diabetes among North American Persons in HIV Care - (10/7/19)   IDWeek 2019: Possible Higher Diabetes Risk With INSTIs or PIs Than NNRTIs - Mark Mascolini (10/4/19)   IDWeek: Weight Change Associated with Switching to Integrase Strand Transfer Inhibitor-based Antiretroviral Regimens in HIV-positive Subjects - (10/11/19)   IDWeek 2019: Antiretroviral Therapy Anchor-based Trends in Body Mass Index following Treatment Initiation among Military Personnel with HIV - (10/11/19)   IDWeek 2019: Effects of Integrase Strand-Transfer Inhibitor Use on Lipids, Glycemic Control, and Insulin Resistance in the Women's Interagency HIV Study (WIHS) - (10/8/19)   IDWeek 2019: Risk of type-2 diabetes mellitus after initiating integrase and protease inhibitors in individuals living with HIV in the United States - (10/8/19)   IDWeek: Weight Rises--But Lipids and HbA1c Don't--After Switch to Integrase Drugs - Mark Mascolini (10/7/19)   IDWeek: The prevalence and burden of non-aids comorbidities in women with or at-risk for hiv infection in the united states - (10/8/19)   IDWeek 2019: Changes in BMI associated with antiretroviral regimens in treatment-experienced, virologically suppressed individuals living with HIV - (10/8/19)   IDWeek 2019: Over Half of Mostly Black US HIV Group Has NAFLD--and Many Have NASH - Mark Mascolini (10/4/19)   IDWeek: A Comparison Study of Prevalence and Risk Factors for Nonalcoholic Fatty Liver Disease (NAFLD) and Nonalcoholic Steatohepatitis (NASH) by Transient Elastography (TE) in HIV Infected Patients - (10/8/19)   IDWeek 2019: Hepatic Steatosis in People Living with HIV - Effect of Sex and Race/Ethnicity - (10/16/19)   IDWeek 2019: - Higher Steatosis Risk in HIV+ Hispanics, But No Link to Integrase Inhibitors - Mark Mascolini (10/4/19)   IDWeek IDSA October 2 -6 2019 Washington, DC           View Older Articles   Back to Top   www.natap.org